Product Reports Resources Pricing Login Book a demo

Rigel Pharmaceuticals

Biotech & Life Sciences · South San Francisco, United States · Founded 1996 · IPO 2000

Small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases

Valuation $580M
Revenue $279M
EBITDA $51M
Power Law Thoroughbred$100M+ revenue

Talent graph

Rigel Pharmaceuticals's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 7 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

3 investors on Rigel Pharmaceuticals's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 1 investor entered at this stage
Frazier Healthcare Partners
Series B+ 2 investors entered at this stage
Stanford University
NEA

Rigel Pharmaceuticals mafia

Startups founded by Rigel Pharmaceuticals alumni

Former Rigel Pharmaceuticals employees who went on to start their own companies. Sorted by Dealroom signal score.

MyDefenceEst. 2013
Dan HermansenDenmark
Signal score90
Shinobi TherapeuticsEst. 2023
Donald PayanUnited States
Signal score83
Immune-Onc TherapeuticsEst. 2016
Charlene LiaoUnited States
Signal score64
Cognition TherapeuticsEst. 2007
SCSusan CatalanoUnited States
Signal score63
BiPar SciencesEst. 2002
VPValeria Ossovskaya, PhDUnited States
Signal score58
alive.cnEst. 2011
Brian WongChina
Signal score52
ProteolixEst. 2003
Susan MolineauxUnited States
Signal score0

Book a demo to explore the full alumni network →

Global footprint

Where Rigel Pharmaceuticals has talent and traffic

Workforce by country
4 countries with
team presence
🇺🇸 United States97.3%
🇮🇳 India0.7%
🇮🇹 Italy0.7%
🇬🇭 Ghana0.7%
4 countries shown
Web traffic by country
12K monthly visits
across markets
🇺🇸 United States62.5%
🇨🇦 Canada19.2%
🇮🇳 India13.3%
🇯🇵 Japan8.3%
Top 4 markets shown

Patent intelligence

Rigel Pharmaceuticals’s patent portfolio

Estimated portfolio value
$248M

144 active families in the valuation dataset.

Source: Dealroom Patent Intelligence · PatSnap. Portfolio estimates and the family records below have different coverage.

Compare patent portfolios across companies →

Market sentiment

What the market is saying about Rigel Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Rigel Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Rigel Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles